rs1277466514
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001039141.3(TRIOBP):c.5869C>T(p.Gln1957Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000194 in 1,547,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001039141.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.5869C>T | p.Gln1957Ter | stop_gained | 16/24 | ENST00000644935.1 | NP_001034230.1 | |
TRIOBP | NM_007032.5 | c.730C>T | p.Gln244Ter | stop_gained | 6/14 | NP_008963.3 | ||
TRIOBP | NM_138632.2 | c.730C>T | p.Gln244Ter | stop_gained | 6/8 | NP_619538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.5869C>T | p.Gln1957Ter | stop_gained | 16/24 | NM_001039141.3 | ENSP00000496394 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000134 AC: 2AN: 149640Hom.: 0 AF XY: 0.0000250 AC XY: 2AN XY: 80106
GnomAD4 exome AF: 0.00000143 AC: 2AN: 1395656Hom.: 0 Cov.: 32 AF XY: 0.00000291 AC XY: 2AN XY: 687964
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 08, 2016 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gln1957X variant in exon 16 of TRIOBP (NM_001039141.2) has not been previously reported i n individuals with hearing loss. Data from large population studies is insuffici ent to assess the frequency of this variant. This nonsense variant leads to a pr emature termination codon at position 1957 which is predicted to lead to a trunc ated or absent protein. However, several TRIOBP isoforms exist. In humans, a lon g isoform is reportedly expressed in the cochlea and a short isoform is ubiquito usly expressed (Kitajiri 2010). To date, all truncating or loss of function var iants in TRIOBP reported in individuals with hearing loss are located in exon 7 of the long isoform (NM_001039141.2), which does not overlap with exons in the s hort isoform. Furthermore, a mouse model showed that a homozygous deletion of th e exon 7 mouse homologue was profoundly deaf, but simultaneous knockout of both isoforms was embryonic lethal (Kitajiri 2010), suggesting that the long isoform is essential for hearing while the short isoform has an additional essential dev elopmental role in mice. However, biallelic truncating variants have not been re ported outside of exon 7 in patients with hearing loss, and biallelic truncating variants or loss of function variants that affect both isoforms have not been r eported in patients or individuals in control databases. In summary, while this variant is likely to result in a truncated or absent protein and may be disease causing, the clinical significance of this variant is uncertain due to limited d ata on truncating variants outside of exon 7 of the long isoform of the TRIOBP g ene. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at